Global Type 2 Diabetes Mellitus Market: Investment in First-in-Class Innovation Remains Strong
Dublin, May 11, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating …